|From: singhtelecom (Rep: 974)||Date: 03/26/2020 23:50|
|Forum: Amarin Corporation plc - Msg #1894||Thread #674137235 (Rec: 0) |
| 3,500 April 3rd $15 calls bought for about $1.35. Now it looks like calls are rolling back|
with 20,000 April $20 calls closing for $0.50 and 20,000 April $13 calls bought for $3.10. Will confirm
tomorrow if those April $20 calls are rolling back or if a call spread is opening. Either way, the $13 calls
are being bought. In December, the FDA approved Amarin's drug VASCEPA (reduces cardiovascular risk).
There's been bullish analyst coverage recently...
3/2 - Cowen initiated Outperform rating with $23 PT
3/2 - Cantor Fitzgerald was positive on VASCEPA, said shares "could trade toward $35"
3/13 - Goldman Sachs upgraded to Buy with a $28 PT
There's been some bullish trades in Amarin recently, including $5.6 million worth of April $12 calls
bought on 3/17.
TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.